⌘K

Home/Filings/4/0001618835-20-000157

4//SEC Filing

Culwell Kelly 4

Accession 0001618835-20-000157

CIK 0001618835other

View on SEC.gov Company Profile

Filed

May 25, 8:00 PM ET

Accepted

May 26, 5:16 PM ET

Size

4.9 KB

Accession

0001618835-20-000157

Insider Transaction Report

Form 4

Period: 2020-05-22

Evofem Biosciences, Inc.EVFM

Chief Medical Officer

Transactions

Tax Payment
Common Stock
2020-05-22$4.99/sh−39,435$196,781→ 146,999 total

Footnotes (1)

[F1]Shares withheld by the Issuer to satisfy statutory tax withholding requirements upon vesting of restricted stock awards occurring on May 22, 2020. No shares were sold in connection with this transaction.

Documents

1 file

4
wf-form4_159052777118613.xmlPrimary
FORM 4

Issuer

Evofem Biosciences, Inc.

CIK 0001618835

Entity typeother

Related Parties

1

filerCIK 0001726183

Filing Metadata

Form type: 4
Filed: May 25, 8:00 PM ET
Accepted: May 26, 5:16 PM ET
Size: 4.9 KB

View on SEC.gov